NASDAQ · Biotechnology

Ascendis Pharma A/S - Ordinary Share (ASND) Stock

$222.69 -2.50% NASDAQ: ASND Healthcare

Valuation

MetricValue
Price$222.69
Market Cap$13.83B
P/E Ratio16.85
P/B Ratio9.14
P/S Ratio12.01
EPS (TTM)$10.37
52-Week High$282.15
52-Week Low$186.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE190.44%
ROA33.08%
ROCE6.01%
Gross Margin88.17%
Operating Margin-0.80%
Net Margin71.69%
Debt/Equity0.31
Current Ratio1.04

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$51.0M$267.0M$364.0M$692.0M
Operating Profit$-452.0M$-562.0M$-456.0M$-279.0M$-131.0M
Net Profit$-384.0M$-583.0M$-481.0M$-378.0M$-219.0M
EPS$-7.00$-10.40$-8.55$-6.53$-3.62
Op Margin-5808.6%-1097.8%-170.8%-76.7%-18.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.1B$1.1B$826.0M$1.2B$1.3B
Total Liabilities$201.0M$826.0M$971.0M$1.3B$1.5B
Cash$446.0M$445.0M$392.0M$560.0M$616.0M
Borrowings$210.0M$618.0M$743.0M$857.0M$871.0M

Latest News

FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo Zacks · Jul 14, 2026 Ascendis Pharma (ASND) Reports Two Year YUVIWEL Trial Data In Achondroplasia Simply Wall St. · Jul 12, 2026 Ascendis Pharma (ASND) Stock Looks Above Fair Value As Shares Jump 24% Simply Wall St. · Jul 12, 2026 Why Crinetics Stock Soared 99% This Week 24/7 Wall St. · Jul 9, 2026 Ascendis Pharma Stock's Strong Momentum to Continue, Wedbush Says MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-418.0M$-496.0M$-467.0M$-306.0M$52.0M
Investing Cash Flow$-135.0M$47.0M$284.0M$5.0M$-16.0M
Financing Cash Flow$-10.0M$-100.0M$8.0M$11.0M$-28.0M
Net Cash Flow$-138.0M$-1.0M$-53.0M$167.0M$123.0M
Free Cash Flow$-442.0M$-510.0M$-470.0M$-308.0M$44.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA157.50
FCF Yield2.66%
Quick Ratio2.32
Interest Coverage0.67
Return 1Y8.42%
Return 3Y152.62%
Return 5Y36.67%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About Ascendis Pharma A/S - Ordinary Share

Ascendis Pharma A/S - Ordinary Share is led by CEO Jan Moller Mikkelsen, employs 1,017 people, headquartered in Hellerup, DK, publicly traded since 2015.

Ascendis Pharma A/S - Ordinary Share (ASND) stock trades at $222.69 with a market capitalization of $13.83B. The stock is valued at a price-to-earnings (P/E) ratio of 16.85, price-to-book of 9.14, price-to-sales of 12.01. Over the past 52 weeks the stock has ranged between $186.05 and $282.15, and currently trades 21.1% below its 52-week high.

On profitability, Ascendis Pharma A/S - Ordinary Share generates a return on equity (ROE) of 190.44% — well above the market average, a sign of a high-quality business, return on capital employed of 6.01%, an operating margin of -0.80%, a net profit margin of 71.69%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides